UBS Makes August Changes to Equity Focus List Portfolio
In a new report, UBS made changes in the firm's Equity Focus list and updated other positions.
In a new report, UBS made changes in the firm's Equity Focus list and updated other positions.
In a new research report, Cowen's well-respected analyst Ken Cacciatore makes a very good case that some huge, high-profile biotech companies could be targeted for buyouts.
SunTrust Robinson Humphrey handicaps some of the upcoming events for stocks in the firm's coverage universe that have potential market-moving clinical and FDA catalysts during the remainder of 2015.
A new comprehensive research report from Merrill Lynch takes a hard look at stocks that can benefit as energy investors wait for an increase in spot prices.
Jefferies analysts are very bullish on four U.S. stocks that they think are outstanding buys now, two of which are total contrarian calls.
ThinkstockAs we have been expecting, as the second quarter earnings reporting period starts to come to a close, the windows at public companies for insiders to make transactions are starting to open again. After…
ThinkstockNothing like earnings season coming around to buy stock if you are an insider and your company happens to disappoint. While most of the S&P 500 companies have reported as August begins, some of…
ThinkstockFor the most part, unless you were way over-weighted to energy, large cap and mega cap stocks did reasonably well for investors this year. At the end of 2014 Savita Subramanian and her top…
ThinkstockThere is one obvious result that always starts to spell the end of a momentum phase in the stock market. When a crowded momentum stock beats earnings estimates and guides higher but still gets…
ThinkstockAlmost any way you look at it, the long stock market run looks like it is starting to hit a wall. The commodity market from oil to gold has been hammered, the dollar has…
ThinkstockWhile the market has had a nice pair of back-to-back rally days, many investors are starting to be concerned on valuations again. That’s the time it makes sense to look at value stocks and…
ThinkstockAll of the major indices rebalance their share weightings on a regular basis as their components change in share price and in market capitalization. Generally speaking on index weightings with true rebalances, market cap…
ThinkstockThe technology industry is one that tends to duplicate itself within the sector. If it appears to be working for one group, and most of all Wall Street seems to applaud, then it may…
ThinkstockAnalysts are constantly using quantitative screens to search the stock universe for what is the best performing category. In a recent report from Merrill Lynch’s Savita Subramanian, the superb strategist at the firm gives…
ThinkstockWhile the long awaited correction may have to wait a day as the markets look ready to rebound, the good news for investors is the economy is looking better and the market should start…
ThinkstockIf any sector has been taking a beating it’s energy, and the price of crude continued the downward spiral last week to under $50 again. With West Texas Intermediate 20% below the June high…
ThinkstockDespite the stock market getting bombed last week, and the Dow Jones Industrial Average actually falling back into the red for the year, things may not be all that bad. Current economic data like…
One thing all biotech investors know is that if a binary event like clinical data goes wrong on a company relying on one specific product, then the end may not be that far behind.
When a sector gets ugly, one of the first things Wall Street looks for is big buyers at much reduced price levels.
24/7 Wall St. screened the Jefferies universe of energy stocks for high-quality companies that are rated Buy. These four jumped out at us.